Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)
复制标题
派姆单抗 (MK-3475) 与安慰剂在接受化疗和放疗的食管癌参与者中的研究 (MK-3475-975/KEYNOTE-975)
DOI：
10.31525/ct1-nct04210115
复制
发表时间：
2019
期刊：
影响因子：
--
通讯作者：
E. Morrato
中科院分区：
文献类型：
--
作者：
Demetria M. McNeal;O. J. Sahler;R. Noll;D. Fairclough;Megan E. Voll;Shubha Bhat;E. Morrato
